Developing and validating multi-omics prediction models for late patient-reported dysphagia in head and neck radiotherapy

Owen Paetkau,Sarah Weppler,Harvey C Quon,Ekaterina Tchistiakova,Charles Kirkby,Harvey Quon

DOI: https://doi.org/10.1088/2057-1976/ad4651

2024-05-03

Biomedical Physics & Engineering Express

Abstract:Background and purpose: To investigate models developed using radiomic and dosiomic (multi-omics) features from planning and treatment imaging for late patient-reported dysphagia in head and neck radiotherapy. Materials and methods: Training (n=64) and testing (n=23) cohorts of head and neck cancer patients treated with curative intent chemo-radiotherapy with a follow-up time greater than 12 months were retrospectively examined. Patients completed the MD Anderson Dysphagia Inventory and a composite score ≤60 was interpreted as patient-reported dysphagia. A chart review collected baseline dysphagia and clinical factors. Multi-omic features were extracted from planning and last synthetic CT images using the pharyngeal constrictor muscle contours as a region of interest. Late patient-reported dysphagia models were developed using a random forest backbone, with feature selection and up-sampling methods to account for the imbalanced data. Models were developed and validated for multi-omic feature combinations for both timepoints. Results: A clinical and radiomic feature model developed using the planning CT achieved good performance (validation: sensitivity=80±27% / balanced accuracy=71±23%, testing: sensitivity =80±10% / balanced accuracy=73±11%). The synthetic CT models did not show improvement over the plan CT multi-omics models, with poor reliability of the radiomic features on these images. Dosiomic features extracted from the synthetic CT showed promise in predicting late patient-reported dysphagia. Conclusion: Multi-omics models can predict late patient-reported dysphagia in head and neck radiotherapy patients. Synthetic CT dosiomic features show promise in developing successful models to account for changes in delivered dose distribution. Multi-center or prospective studies are required prior to clinical implementation of these models.